MedPath

The Essential Newborn Observations and Signs study: Investigating vital sign ranges in well newborns greater than 34 weeks gestation. A prospective observation study

Not Applicable
Completed
Conditions
ewborn Health
Reproductive Health and Childbirth - Childbirth and postnatal care
Newborn Health
Registration Number
ACTRN12618000992202
Lead Sponsor
The University of Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
190
Inclusion Criteria

Inclusion criteria
• Male and Female Newborns born greater than or equal to 34 weeks gestation
• Born via vaginal delivery or caesarean section
• APGAR score greater than or equal to 7
• Well newborn admitted directly to the postnatal ward, or directly to the special care nursery (for routine
observations in accordance with hospital policy that all newborns born less than 35 weeks gestational age or less than 2400g birthweight require initial admission to the special care nursery.

Exclusion Criteria

Exclusion criteria
• Male and Female newborns born less than 34 weeks gestation
• Emergency delivery in which the newborn required resuscitative measures at delivery such as assisted
ventilation; cardiopulmonary resuscitation; or surfactant administration
• Admitted directly to the Neonatal Intensive Care nursery
• Has a known congenital disorder (e.g. cardiac, pulmonary)
• Has signs of respiratory distress or a previous episode of respiratory distress requiring treatment
• Had two or more BGLs of less than 2.6mmol/L
• Had two or more temperatures of less than 36.5°C
• Phototherapy requiring additional supportive management/treatment in SCN
• Born to a mother with a significant medical condition and/or history of recreational drug use during
pregnancy.
• Retrieved from another healthcare facility
• Discharged from the Royal Brisbane and Women’s Hospital then re-admitted

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath